Izraeli S - Search Results

1

Epidemiology of childhood leukemia in the presence and absence of Down syndrome.

Mezei G, Sudan M, Izraeli S, Kheifets L. Mezei G, et al. Among authors: izraeli s. Cancer Epidemiol. 2014 Oct;38(5):479-89. doi: 10.1016/j.canep.2014.07.006. Epub 2014 Aug 10. Cancer Epidemiol. 2014. PMID: 25113940 Review.

2

Minimal residual disease in childhood acute lymphoblastic leukemia: current status and challenges.

Izraeli S, Waldman D. Izraeli S, et al. Acta Haematol. 2004;112(1-2):34-9. doi: 10.1159/000077558. Acta Haematol. 2004. PMID: 15179003 Review.

3

Perspective: chromosomal aneuploidy in leukemia--lessons from down syndrome.

Izraeli S. Izraeli S. Hematol Oncol. 2006 Mar;24(1):3-6. doi: 10.1002/hon.758. Hematol Oncol. 2006. PMID: 16270377 Review.

4

Trisomy of chromosome 21 in leukemogenesis.

Izraeli S, Rainis L, Hertzberg L, Smooha G, Birger Y. Izraeli S, et al. Blood Cells Mol Dis. 2007 Sep-Oct;39(2):156-9. doi: 10.1016/j.bcmd.2007.04.004. Epub 2007 May 29. Blood Cells Mol Dis. 2007. PMID: 17532652 Free article. Review.

5

Array comparative genome hybridization analysis of acute lymphoblastic leukaemia and acute megakaryoblastic leukaemia in patients with Down syndrome.

Lo KC, Chalker J, Strehl S, Neat M, Smith O, Dastugue N, Kearney L, Izraeli S, Kempski H, Cowell JK. Lo KC, et al. Among authors: izraeli s. Br J Haematol. 2008 Sep;142(6):934-45. doi: 10.1111/j.1365-2141.2008.07280.x. Epub 2008 Jun 28. Br J Haematol. 2008. PMID: 18557744 Free article.

6

DYRK1A in Down syndrome: an oncogene or tumor suppressor?

Birger Y, Izraeli S. Birger Y, et al. Among authors: izraeli s. J Clin Invest. 2012 Mar;122(3):807-10. doi: 10.1172/JCI62372. Epub 2012 Feb 22. J Clin Invest. 2012. PMID: 22354166 Free PMC article.

7

Spontaneous remission of childhood acute marrow fibrosis and megakaryoblastic leukemia.

Elhasid R, Tohami T, Moustafa-Hawash N, Ben-Ezra J, Izraeli S, Sayar D. Elhasid R, et al. Among authors: izraeli s. J Pediatr Hematol Oncol. 2012 Oct;34(7):565-8. doi: 10.1097/MPH.0b013e318257a172. J Pediatr Hematol Oncol. 2012. PMID: 22627572

8

How I treat ALL in Down's syndrome: pathobiology and management.

Izraeli S, Vora A, Zwaan CM, Whitlock J. Izraeli S, et al. Blood. 2014 Jan 2;123(1):35-40. doi: 10.1182/blood-2013-07-453480. Epub 2013 Nov 14. Blood. 2014. PMID: 24235135 Free article. Review.

9

Towards precision medicine in childhood leukemia--insights from mutationally activated cytokine receptor pathways in acute lymphoblastic leukemia.

Izraeli S, Shochat C, Tal N, Geron I. Izraeli S, et al. Cancer Lett. 2014 Sep 28;352(1):15-20. doi: 10.1016/j.canlet.2014.02.009. Epub 2014 Feb 22. Cancer Lett. 2014. PMID: 24569093 Review.

10

MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome.

Shaham L, Vendramini E, Ge Y, Goren Y, Birger Y, Tijssen MR, McNulty M, Geron I, Schwartzman O, Goldberg L, Chou ST, Pitman H, Weiss MJ, Michaeli S, Sredni B, Göttgens B, Crispino JD, Taub JW, Izraeli S. Shaham L, et al. Among authors: izraeli s. Blood. 2015 Feb 19;125(8):1292-301. doi: 10.1182/blood-2014-06-581892. Epub 2014 Dec 22. Blood. 2015. PMID: 25533034 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

232 results

Search Page